Bispecific antibody-activated T cells enhance NK cell-mediated antibody-dependent cellular cytotoxicity

por Wang, Zhaoming, Yin, Chaobo, Lum, Lawrence G., Simons, Andrean, Weiner, George J.
Publicado 2021

Interleukin-1 blockade overcomes erlotinib resistance in head and neck squamous cell carcinoma

por Stanam, Aditya, Gibson-Corley, Katherine N., Love-Homan, Laurie, Ihejirika, Nnamdi, Simons, Andrean L.
Publicado 2016

Inhibition of Glutathione and Thioredoxin Metabolism Enhances Sensitivity to Perifosine in Head and Neck Cancer Cells

por Simons, Andrean L., Parsons, Arlene D., Foster, Katherine A., Orcutt, Kevin P., Fath, Melissa A., Spitz, Douglas R.
Publicado 2009

The Justy mutant mouse strain produces a spontaneous murine model of salivary gland cancer with myoepithelial and basal cell differentiation

por Simons, Andrean L., Lu, Ping, Gibson-Corley, Katherine N., Robinson, Robert A., Meyerholz, David K., Colgan, John D.
Publicado 2013

2-Deoxy-d-glucose Suppresses the In Vivo Antitumor Efficacy of Erlotinib in Head and Neck Squamous Cell Carcinoma Cells

por Sobhakumari, Arya, Orcutt, Kevin P., Love-Homan, Laurie, Kowalski, Christopher E., Parsons, Arlene D., Knudson, C. Michael, Simons, Andrean L.
Publicado 2016

Prognostic Role of Combined EGFR and Tumor-Infiltrating Lymphocytes in Oral Squamous Cell Carcinoma

por Wongpattaraworakul, Wattawan, Gibson-Corley, Katherine N., Choi, Allen, Buchakjian, Marisa R., Lanzel, Emily A., Rajan KD, Anand, Simons, Andrean L.
Publicado 2022

In situ immunization of a TLR9 agonist virus-like particle enhances anti-PD1 therapy

por Cheng, Yinwen, Lemke-Miltner, Caitlin D, Wongpattaraworakul, Wattawan, Wang, Zhaoming, Chan, Carlos H F, Salem, Aliasger K, Weiner, George J, Simons, Andrean L
Publicado 2020

Susceptibility of Human Head and Neck Cancer Cells to Combined Inhibition of Glutathione and Thioredoxin Metabolism

por Sobhakumari, Arya, Love-Homan, Laurie, Fletcher, Elise V. M., Martin, Sean M., Parsons, Arlene D., Spitz, Douglas R., Knudson, C. Michael, Simons, Andrean L.
Publicado 2012

Impact of Nuclear Interleukin-1 Alpha and EGFR Expression on Recurrence and Survival Outcomes in Oral Squamous Cell Carcinomas

por Rajan, Anand, Gibson-Corley, Katherine N., Choi, Allen B., Ofori-Amanfo, Georgina K., Ten Eyck, Patrick, Espinosa-Cotton, Madelyn, Sperry, Steven M., Simons, Andrean L.
Publicado 2019

A preliminary analysis of interleukin-1 ligands as potential predictive biomarkers of response to cetuximab

por Espinosa-Cotton, Madelyn, Fertig, Elana J., Stabile, Laura P., Gaither-Davis, Autumn, Bauman, Julie E., Schmitz, Sandra, Gibson-Corley, Katherine N., Cheng, Yinwen, Jensen, Isaac J., Badovinac, Vladimir P., Laux, Douglas, Simons, Andrean L.
Publicado 2019

The anti-tumor effects of cetuximab in combination with VTX-2337 are T cell dependent

por Cheng, Yinwen, Borcherding, Nicholas, Ogunsakin, Ayomide, Lemke-Miltner, Caitlin D., Gibson-Corley, Katherine N., Rajan, Anand, Choi, Allen B., Wongpattaraworakul, Wattawan, Chan, Carlos H. F., Salem, Aliasger K., Weiner, George J., Simons, Andrean L.
Publicado 2021

Interleukin-1 alpha increases anti-tumor efficacy of cetuximab in head and neck squamous cell carcinoma

por Espinosa-Cotton, Madelyn, Rodman III, Samuel N., Ross, Kathleen A., Jensen, Isaac J., Sangodeyi-Miller, Kenley, McLaren, Ayana J., Dahl, Rachel A., Gibson-Corley, Katherine N., Koch, Adam T., Fu, Yang-Xin, Badovinac, Vladimir P., Laux, Douglas, Narasimhan, Balaji, Simons, Andrean L.
Publicado 2019